The latest FDA approval was based on the results of the ADVANCE trial, which showed that five times as many adults with mild to moderate plaque psoriasis receiving oral Otezla 30 mg twice daily ...

Amgen maintains that Otezla remains the only approved oral systemic therapy with a broad indication and is “well positioned” to help the 4 million US patients with mild to moderate psoriasis ...

While there are plenty of over-the-counter psoriasis treatments, you’ll probably need a prescription medication unless you have a very mild case. Psoriasis can cause red, dry, itchy skin patches ...

Topical roflumilast 0.3% cream has been approved by the FDA to treat plaque psoriasis in patients 12 years and older since ...

The usual maintenance dosage of Otezla (apremilast) is two 30-mg doses per day. It’s important to take the Otezla dosage your doctor prescribes. Otezla belongs to a class of drugs called disease ...

Topical therapies are relatively low-cost and usually the first approach in people with mild to moderate psoriasis ...

New research shows that in patients with psoriasis, even though their skin responds well to treatment with biologics, ...

The American Academy of Dermatology/National Psoriasis Foundation (AAD/NPF) guidelines state that "topical medications are the most common agents used to treat patients with mild or moderate ...